Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.
Yamaguchi Y, Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Sugiyama K, Ogasawara Y, Saito T, Minami J, Kobayashi T, Katsube A, Kamiyama Y, Machishima T, Morikawa N, Otsubo H, Kaito K, Asai O, Aiba K.
Yamaguchi Y, et al. Among authors: ogasawara y.
Gan To Kagaku Ryoho. 2009 Jul;36(7):1105-9.
Gan To Kagaku Ryoho. 2009.
PMID: 19620797